锦欣生殖(01951.HK)12月17日耗资1212.1万港元回购482.5万股
Group 1 - The company, Jinxin Reproductive Medicine (01951.HK), announced a share buyback on December 17, 2023, spending HKD 12.121 million to repurchase 4.825 million shares [1]
Group 1 - The company, Jinxin Reproductive Medicine (01951.HK), announced a share buyback on December 17, 2023, spending HKD 12.121 million to repurchase 4.825 million shares [1]